Advancing imaging biomarker development and translation through the National Cancer Imaging Translational Accelerator (NCITA)

It is estimated that someone is diagnosed with cancer every two minutes in the UK. Clinical imaging offers a minimally invasive way of diagnosing and managing a variety of cancers. The National Cancer Imaging Translational Accelerator (NCITA) consortium now provides researchers with the infrastructu...

وصف كامل

التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: McAteer, M, Higgins, G
التنسيق: Internet publication
اللغة:English
منشور في: Research Outreach 2022
_version_ 1826312587895111680
author McAteer, M
Higgins, G
author_facet McAteer, M
Higgins, G
author_sort McAteer, M
collection OXFORD
description It is estimated that someone is diagnosed with cancer every two minutes in the UK. Clinical imaging offers a minimally invasive way of diagnosing and managing a variety of cancers. The National Cancer Imaging Translational Accelerator (NCITA) consortium now provides researchers with the infrastructure to conduct high-quality, multi-centre clinical research in the quest to develop standardised imaging biomarkers and accelerate their translation into clinical use. The NCITA consortium and collaborators aim to improve clinical outcomes for patients through early cancer identification and new treatment discoveries.
first_indexed 2024-03-07T03:46:47Z
format Internet publication
id oxford-uuid:bfbfe00b-58cd-45e6-a8a3-db5d19c4f497
institution University of Oxford
language English
last_indexed 2024-04-09T03:57:05Z
publishDate 2022
publisher Research Outreach
record_format dspace
spelling oxford-uuid:bfbfe00b-58cd-45e6-a8a3-db5d19c4f4972024-03-21T14:46:32ZAdvancing imaging biomarker development and translation through the National Cancer Imaging Translational Accelerator (NCITA)Internet publicationhttp://purl.org/coar/resource_type/c_7ad9uuid:bfbfe00b-58cd-45e6-a8a3-db5d19c4f497EnglishSymplectic ElementsResearch Outreach2022McAteer, MHiggins, GIt is estimated that someone is diagnosed with cancer every two minutes in the UK. Clinical imaging offers a minimally invasive way of diagnosing and managing a variety of cancers. The National Cancer Imaging Translational Accelerator (NCITA) consortium now provides researchers with the infrastructure to conduct high-quality, multi-centre clinical research in the quest to develop standardised imaging biomarkers and accelerate their translation into clinical use. The NCITA consortium and collaborators aim to improve clinical outcomes for patients through early cancer identification and new treatment discoveries.
spellingShingle McAteer, M
Higgins, G
Advancing imaging biomarker development and translation through the National Cancer Imaging Translational Accelerator (NCITA)
title Advancing imaging biomarker development and translation through the National Cancer Imaging Translational Accelerator (NCITA)
title_full Advancing imaging biomarker development and translation through the National Cancer Imaging Translational Accelerator (NCITA)
title_fullStr Advancing imaging biomarker development and translation through the National Cancer Imaging Translational Accelerator (NCITA)
title_full_unstemmed Advancing imaging biomarker development and translation through the National Cancer Imaging Translational Accelerator (NCITA)
title_short Advancing imaging biomarker development and translation through the National Cancer Imaging Translational Accelerator (NCITA)
title_sort advancing imaging biomarker development and translation through the national cancer imaging translational accelerator ncita
work_keys_str_mv AT mcateerm advancingimagingbiomarkerdevelopmentandtranslationthroughthenationalcancerimagingtranslationalacceleratorncita
AT higginsg advancingimagingbiomarkerdevelopmentandtranslationthroughthenationalcancerimagingtranslationalacceleratorncita